Plexxikon
Scaffold-Based Drug Discovery
Cardio-Renal
CNS
Inflammation
Metabolic Disease
Oncology
Cardio-Renal
CNS
Inflammation
Metabolic Disease
Oncology
About
Management
Pipeline
Cardio-Renal
CNS
Inflammation
Metabolic Disease
Oncology
Clinical Trials
Partners
News
Press Releases
Press Kit
Careers
Contact Us
Driving Directions
Plexxikon News
02/19/2012
Plexxikon Announces European Approval of Zelboraf® for the Treatment of Patients with BRAF Mutation-Positive Metastatic Melanoma
12/12/2011
Plexxikon Advances Novel Targeted Treatment of PLX3397 in Blood Cancer
11/13/2011
Plexxikon Novel Agents Aim To Address Cancer Treatment in New Ways